Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

RNS System NAUTILUS Study

NCT: NCT05147571 · COMPLETED

NCT IDNCT05147571

StatusCOMPLETED

Start Date2022-08-09

Completion2026-03-31

SponsorNeuroPace (INDUSTRY)

First posted2021-12-07

Last updated2026-06-08

Brief Summary

To demonstrate that the RNS System for thalamic stimulation is safe and effective as an adjunctive therapy for the reduction of primary generalized seizures in individuals 12 years of age or older who have drug-resistant idiopathic generalized epilepsy.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑